Lucid Diagnostics Inc (LUCD)

Finanzdaten der Lucid Diagnostics Inc-Aktie (LUCD)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	3.75% 1.001	1.04	0.783	0.159	0.446
Operating Expenses	5.60% 11.79	12.49	11.91	11.74	14.76
Interest Income/Expense	0.012	-	-	-	-
Benefits Costs and Expenses	2.17% 11.61	11.87	14.99	11.54	16.69
Costs And Expenses	2.17% 11.61	11.87	14.99	11.74	16.69
Operating Income/Loss	5.77% -10.79	-11.45	-11.13	-11.58	-14.32
Income/Loss From Continuing Operations Before Tax	2.01% -10.61	-10.83	-14.21	-11.38	-16.25
Income/Loss From Continuing Operations After Tax	2.01% -10.61	-10.83	-14.21	-11.38	-16.25
Net Income/Loss	2.01% -10.61	-10.83	-14.21	-11.38	-16.25
Preferred Stock Dividends And Other Adjustments	7.496	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	22,733% 45.01	0.1972	41.86	41.83	40.97
Diluted Average Shares	22,733% 45.01	0.1972	41.86	41.83	-0.4293
Basic Earnings Per Share	60.00% -0.40	-0.25	-0.34	-0.27	-0.40
Diluted Earnings Per Share	60.00% -0.40	-0.25	-0.34	-0.27	-0.40
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	7.496	-	-	-	-